Maeil Dairies (KOSDAQ:267980) will expand its supply of specialized infant formula for congenital metabolic disorders to China via Alibaba Health (HKG:0241), Pulse News reported Thursday.
The South Korean infant formula maker will offer 12 products across eight categories in the Chinese market. This expansion follows a charity partnership with Alibaba Health that was signed in May, the report said.
Maeil Dairies will also host an exchange meeting in September to discuss congenital metabolic disorders with healthcare professionals and families from South Korea and China, it said.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Comments